Gravitate Health FHIR Implementation Guide
0.1.0 - CI Build

Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health and changes regularly. See the Directory of published versions

Example Composition: Composition for Package leaflet: Information for the patient Talzenna® (talazoparib) 0.25 mg and 1mg hard capsules

Generated Narrative: Composition

Resource Composition "compositionUkEnPersonalizedTalzenna" (Language "en")

Profile: Composition (ePI)

HtmlElementLink

url

elementClass

value: breastCancer

url

concept

value: Breast Cancer (SNOMED CT#254837009)

HtmlElementLink

url

elementClass

value: contraindication

url

concept

value: Contraindicated (qualifier value) (SNOMED CT#410536001)

HtmlElementLink

url

elementClass

value: Female

url

concept

value: Female (SNOMED CT#248152002)

HtmlElementLink

url

elementClass

value: drugDrugInteraction

url

concept

value: Drug interaction with drug (finding) (SNOMED CT#404204005)

HtmlElementLink

url

elementClass

value: strength025

url

concept

value: strength 0.25 mg (example.org#100)

HtmlElementLink

url

elementClass

value: strength1

url

concept

value: strength 1 mg (example.org#101)

identifier: id: 0d69fdcb-33cf-407f-8209-a6529856ab4f

status: final

type: Package Leaflet (#100000155538)

date: 2022-03-04 00:00:00+0000

author: Organization/orgpfizerukltd1 "Pfizer Limited"

title: Talzenna® (talazoparib) 0.25 mg and 1mg hard capsules